Sign In
Buy RNXT
$0.96
+0.0171 (+1.82%)
At Close: Jul 31, 2026
RNXT Stock Alert: 5 Things to Know as RenovoRx Soars 100%+ Today
10:13am, Wednesday, 10'th Nov 2021
RenovoRx (RNXT) stock is rocketing higher today thanks to a presentation of data at a medical conference yesterday evening. The post RNXT Stock Alert: 5 Things to Know as RenovoRx Soars 100%+ Today ap
RNXT Stock: The FDA News That Has Biotech Company RenovoRx Rocketing Higher Today
10:51am, Tuesday, 07'th Sep 2021
RenovoRx (RNXT) stock is running higher on Tuesday following news that the U.S. Food and Drug Administration granted it new 501(k) clearance. The post RNXT Stock: The FDA News That Has Biotech Company
RNXT Stock: Over 50% Increase Pre-Market Explanation
06:25am, Tuesday, 07'th Sep 2021
The stock price of RenovoRx Inc (NASDAQ: RNXT) increased by over 50% pre-market. This is why it happened.
See Why RenovoRx Stock Is Shooting Higher On Tuesday
06:24am, Tuesday, 07'th Sep 2021
The FDA has granted a new 510(k) clearance to RenovoRx Inc's (NASDAQ:RNXT) RenovoCath Delivery System. The RenovoCath Delivery System is the device component of the Company's initial product, R
RenovoRx Receives New 510(k) Clearance for its RenovoCath® Delivery System Designed for Targeted Treatment of Solid Tumors
06:00am, Tuesday, 07'th Sep 2021
LOS ALTOS, Calif., Sept. 7, 2021 /PRNewswire/ -- RenovoRx , Inc. (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced it has received a new 510(k) c
RenovoRx Proposes Terms For $22 Million IPO
07:10pm, Friday, 13'th Aug 2021
RenovoRx has filed to raise $22.2 million in an IPO. The firm is in Phase 3 clinical trials for its novel drug delivery system for cancer treatments.
